Trial
NCT03287947
LCI-GI-APX-NIN-001: Nintedanib in Metastatic Appendiceal Carcinoma
Phase IITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Wake Forest University Health Sciences
Collaborators
Boehringer Ingelheim
Condition
Appendix Cancer
Intervention
nintedanib
Why stopped
Low enrollment
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2022-08-09